Pediatrix Medical Group (NYSE:MD – Get Free Report) announced its quarterly earnings data on Tuesday. Here are the key takeaways from Pediatrix Medical Group’s conference call:Get Pediatrix Medical Group alerts:Q2 adjusted EBITDA was $76 million , and management reaffirmed its 2026 adjusted EBITDA outlook of $280 million–$300 million . Pediatrix Medical Group Earnings Call: Pricing Over VolumesThe earnings call’s key theme was that higher pricing is offsetting weaker or limited patient-volume growth. Pediatrix Medical Group Company Profile(Get Free Report)Pediatrix Medical Group, Inc (NYSE:MD) is a national physician-led medical group specializing in high-acuity newborn, maternal-fetal and pediatric subspecialty care. Further ReadingReceive News & Ratings for Pediatrix Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pediatrix Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.